Prospective Clinical Trial of Intravitreal Aflibercept Treat-and-extend Regimen for Diabetic Macular Edema: 1-Year Outcomes
Hiroki Mieno, Kazuhito Yoneda, Nobuhiro Terao, Kengo Yoshii, Kentaro Kojima, Kenji Nagata, Chie Sotozono
Korean J Ophthalmol. 2020;34(4):290-296.   Published online 2020 Jul 31     DOI: https://doi.org/10.3341/kjo.2020.0003
Citations to this article as recorded by Crossref logo
Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes
Gurkaran S. Sarohia, Keean Nanji, Mohammad Khan, Muhammad F. Khalid, Daniel Rosenberg, Deven M. Deonarain, Mark R. Phillips, Lehana Thabane, Peter K. Kaiser, Sunir J. Garg, Sobha Sivaprasad, Charles C. Wykoff, Varun Chaudhary
Survey of Ophthalmology.2022;[Epub]     CrossRef
Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial
Takao Hirano, Yuichi Toriyama, Yoshihiro Takamura, Masahiko Sugimoto, Taiji Nagaoka, Yoshimi Sugiura, Fumiki Okamoto, Michiyuki Saito, Kousuke Noda, Shigeo Yoshida, Akihiro Ishibazawa, Osamu Sawada, Toshinori Murata
Japanese Journal of Ophthalmology.2021; 65(3): 354.     CrossRef
Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema
Yu Cheol Kim, Jae Pil Shin, Kang Yeun Pak, Hyun Woong Kim, Min Sagong, Sang Joon Lee, In Young Chung, Sung Who Park, Ji Eun Lee
Scientific Reports.2020;[Epub]     CrossRef